IKT
Price
$2.72
Change
-$0.04 (-1.45%)
Updated
Jan 17 closing price
Capitalization
188.67M
OPORF
Price
$0.28
Change
-$0.09 (-24.32%)
Updated
Jan 6 closing price
Capitalization
150.67M
Ad is loading...

IKT vs OPORF

Header iconIKT vs OPORF Comparison
Open Charts IKT vs OPORFBanner chart's image
Inhibikase Therapeutics
Price$2.72
Change-$0.04 (-1.45%)
Volume$39.87K
Capitalization188.67M
OPEN ORPHAN
Price$0.28
Change-$0.09 (-24.32%)
Volume$3K
Capitalization150.67M
IKT vs OPORF Comparison Chart
Loading...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKT vs. OPORF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a Hold and OPORF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (IKT: $2.72 vs. OPORF: $0.28)
Brand notoriety: IKT and OPORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 13% vs. OPORF: 409%
Market capitalization -- IKT: $188.67M vs. OPORF: $150.67M
IKT [@Biotechnology] is valued at $188.67M. OPORF’s [@Biotechnology] market capitalization is $150.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 0 FA rating(s) are green whileOPORF’s FA Score has 1 green FA rating(s).

  • IKT’s FA Score: 0 green, 5 red.
  • OPORF’s FA Score: 1 green, 4 red.
According to our system of comparison, both IKT and OPORF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 4 TA indicator(s) are bullish.

  • IKT’s TA Score: 4 bullish, 4 bearish.

Price Growth

IKT (@Biotechnology) experienced а -7.80% price change this week, while OPORF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

IKT is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IKT($189M) has a higher market cap than OPORF($151M). IKT YTD gains are higher at: -16.308 vs. OPORF (-24.749).
IKTOPORFIKT / OPORF
Capitalization189M151M125%
EBITDA-20.04MN/A-
Gain YTD-16.308-24.74966%
P/E RatioN/A8.96-
Revenue0N/A-
Total Cash3.24MN/A-
Total Debt145KN/A-
TECHNICAL ANALYSIS
Technical Analysis
IKT
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
79%
View a ticker or compare two or three
Ad is loading...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

IKT and

Correlation & Price change

A.I.dvisor tells us that IKT and OPORF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and OPORF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
-1.45%
OPORF - IKT
29%
Poorly correlated
N/A
EVAX - IKT
25%
Poorly correlated
-8.04%
CDTX - IKT
25%
Poorly correlated
+2.12%
IMNM - IKT
23%
Poorly correlated
+1.32%
CDXC - IKT
23%
Poorly correlated
+5.13%
More

OPORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with KURA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
KURA - OPORF
62%
Loosely correlated
+1.11%
EVAX - OPORF
53%
Loosely correlated
-8.04%
PCSA - OPORF
51%
Loosely correlated
-6.59%
VERA - OPORF
50%
Loosely correlated
+1.80%
ONCO - OPORF
47%
Loosely correlated
+3.37%
More